Merida Biosciences

Science & Engineering · Biotechnology
Lately:4 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often have poor efficacy and come with a risk of serious side effects.

Founded
2021
Website
meridabio.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

top 7%Web presenceof 133.2M domains by links, Common Crawl
Aug 312026
News · YahooFinance
Eli Lilly and Co (NYSE:LLY) said on Monday it will acquire privately held Merida Biosciences for up to $2.88 billion in cash, part of a deal-making push to broaden its treatments…
Aug 312026
News · domain-b.com
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, adding MER511 and a precision antibody-degradation platform to its immunology pipeline.
Aug 312026
News · Pulse 2.0
Eli Lilly and Company has agreed to acquire Merida Biosciences for up to $2.875 billion in cash, adding a precision immunology platform designed to selectively eliminate disease-…
Aug 312026
News · markets.ft.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Sources: the outlets named on each headline, each story once